GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TFF Pharmaceuticals Inc (FRA:0K30) » Definitions » Total Equity

TFF Pharmaceuticals (FRA:0K30) Total Equity : €8.77 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is TFF Pharmaceuticals Total Equity?

TFF Pharmaceuticals's total equity for the quarter that ended in Dec. 2023 was €8.77 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

TFF Pharmaceuticals Total Equity Historical Data

The historical data trend for TFF Pharmaceuticals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TFF Pharmaceuticals Total Equity Chart

TFF Pharmaceuticals Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial 24.88 30.69 34.28 21.60 8.77

TFF Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.60 15.45 11.34 12.83 8.77

TFF Pharmaceuticals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

TFF Pharmaceuticals's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=11.029-2.256
=8.77

TFF Pharmaceuticals's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=11.029-2.256
=8.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TFF Pharmaceuticals Total Equity Related Terms

Thank you for viewing the detailed overview of TFF Pharmaceuticals's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

TFF Pharmaceuticals (FRA:0K30) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TFF Pharmaceuticals Inc (FRA:0K30) » Definitions » Total Equity
Comparable Companies
COCP NRBO LSTA CNTX QSAM NTRB AXLA FRES SYBX KALA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
TFFP:USA
Address
1751 River Run, Suite 400, Fort Worth, TX, USA, 76107
Website
https://www.tffpharma.com
TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It is focused on the development of inhaled dry powder drugs for the treatment of lung disorders.

TFF Pharmaceuticals (FRA:0K30) Headlines

No Headlines